225 related articles for article (PubMed ID: 17359538)
1. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
2. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
[TBL] [Abstract][Full Text] [Related]
4. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
Black KL; Yin D; Konda BM; Wang X; Hu J; Ko MK; Bayan JA; Sacapano MR; Espinoza AJ; Ong JM; Irvin D; Shu Y
Brain Res; 2008 Aug; 1227():198-206. PubMed ID: 18602898
[TBL] [Abstract][Full Text] [Related]
5. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
Ningaraj NS; Rao MK; Black KL
Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.
Uchida M; Chen Z; Liu Y; Black KL
Neurol Res; 2002 Dec; 24(8):739-46. PubMed ID: 12500695
[TBL] [Abstract][Full Text] [Related]
7. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier.
Ningaraj NS; Rao M; Black KL
Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Zhang H; Xue YX
Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
[TBL] [Abstract][Full Text] [Related]
9. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
Gu YT; Xue YX; Wei XY; Zhang H; Li Y
Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
[TBL] [Abstract][Full Text] [Related]
10. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
[TBL] [Abstract][Full Text] [Related]
11. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
12. NS1619 regulates the expression of caveolin-1 protein in a time-dependent manner via ROS/PI3K/PKB/FoxO1 signaling pathway in brain tumor microvascular endothelial cells.
Cai RP; Xue YX; Huang J; Wang JH; Wang JH; Zhao SY; Guan TT; Zhang Z; Gu YT
J Neurol Sci; 2016 Oct; 369():109-118. PubMed ID: 27653874
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
Zhang H; Gu YT; Xue YX
Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
[TBL] [Abstract][Full Text] [Related]
14. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
Black KL; Ningaraj NS
Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model.
Gu YT; Qin LJ; Qin X; Xu F
Neurosci Lett; 2009 Mar; 452(2):114-8. PubMed ID: 19135131
[TBL] [Abstract][Full Text] [Related]
16. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
17. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
18. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.
Liu Y; Hashizume K; Chen Z; Samoto K; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Jun; 23(4):379-87. PubMed ID: 11428519
[TBL] [Abstract][Full Text] [Related]
19. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y
J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
Xia CY; Zhang Z; Xue YX; Wang P; Liu YH
J Neurooncol; 2009 Aug; 94(1):41-50. PubMed ID: 19234812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
